Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

dalfopristin-quinupristin

dalfopristin-quinupristin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Synercid POWDER FOR INJECTION, INTRAVENOUS 350 mg-150 mg      
VIEW MORE Streptogramins
CLASS
08122832
Comments:

**NOTE: Pfizer discontinued Synercid in early 2022. There are currently no other suppliers of the product** (Updated April 2023)

Linezolid is the preferred agent.

Last updated: Apr. 10, 2023






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved